Entry inhibitors

Jump to: navigation, search

WikiDoc Resources for Entry inhibitors

Articles

Most recent articles on Entry inhibitors

Most cited articles on Entry inhibitors

Review articles on Entry inhibitors

Articles on Entry inhibitors in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Entry inhibitors

Images of Entry inhibitors

Photos of Entry inhibitors

Podcasts & MP3s on Entry inhibitors

Videos on Entry inhibitors

Evidence Based Medicine

Cochrane Collaboration on Entry inhibitors

Bandolier on Entry inhibitors

TRIP on Entry inhibitors

Clinical Trials

Ongoing Trials on Entry inhibitors at Clinical Trials.gov

Trial results on Entry inhibitors

Clinical Trials on Entry inhibitors at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Entry inhibitors

NICE Guidance on Entry inhibitors

NHS PRODIGY Guidance

FDA on Entry inhibitors

CDC on Entry inhibitors

Books

Books on Entry inhibitors

News

Entry inhibitors in the news

Be alerted to news on Entry inhibitors

News trends on Entry inhibitors

Commentary

Blogs on Entry inhibitors

Definitions

Definitions of Entry inhibitors

Patient Resources / Community

Patient resources on Entry inhibitors

Discussion groups on Entry inhibitors

Patient Handouts on Entry inhibitors

Directions to Hospitals Treating Entry inhibitors

Risk calculators and risk factors for Entry inhibitors

Healthcare Provider Resources

Symptoms of Entry inhibitors

Causes & Risk Factors for Entry inhibitors

Diagnostic studies for Entry inhibitors

Treatment of Entry inhibitors

Continuing Medical Education (CME)

CME Programs on Entry inhibitors

International

Entry inhibitors en Espanol

Entry inhibitors en Francais

Business

Entry inhibitors in the Marketplace

Patents on Entry inhibitors

Experimental / Informatics

List of terms related to Entry inhibitors


Entry inhibitors are very much similar to Fusion inhibitors. Entry inhibitors are a class of antiretroviral drugs, commonly used in combination therapy in order to treat HIV infection. This class of drugs prevents HIV from binding to gp120 receptor by binding to it itself. This ultimately prevents HIV from binding to the co-receptor, gp41, and from it entering the cell. Entry and fusion inhibitors work differently than the other antiretroviral drugs (reverse transcriptase inhibitors, integrase inhibitors, and protease inhibitors) because these inhibitors work outside of the cell and prevent HIV from entering the host cell in the first place.

The only FDA-approved entry inhibitor is Maraviroc.

References



Linked-in.jpg